Evidence map›Paper›PMID 24099723›Full record

Trial reportNutrition, metabolism, and cardiovascular diseases : NMCD2014

Reduction in dietary trans fat intake is associated with decreased LDL particle number in a primary prevention population.

M Garshick, H Mochari-Greenberger, L Mosca

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

M GarshickPreventive Cardiology Program, Columbia University Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
H Mochari-GreenbergerPreventive Cardiology Program, Columbia University Medical Center/New York-Presbyterian Hospital, New York, NY, USA.
L MoscaPreventive Cardiology Program, Columbia University Medical Center/New York-Presbyterian Hospital, New York, NY, USA. Electronic address: ljm10@columbia.edu.
NewYork–Presbyterian Hospital · US

Funding

Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
POSTDOCTORAL TRAINING IN ARTERIOSCLEROSIS RESEARCHT32HL007343 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI HENRY N GINSBERG, Muredach P Reilly · 1985 to 2026
$12.7M
Family Cardiac Caregiver Investigation to Evaluate Outcomes (FIT-O)R01HL075101 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOSCA, LORI J · 2004 to 2010
$3.5M
Gender Race and Ethnic Disparities Research in Cardiovascular Disease PreventionK24HL076346 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MOSCA, LORI J · 2005 to 2014
$1.7M
NCATS NIH HHS UL1 TR000040NHLBI NIH HHS HL007343NHLBI NIH HHS K24 HL076346NHLBI NIH HHS R01 HL075101NHLBI NIH HHS R01: HL075101NHLBI NIH HHS T32 HL007343
6 · The paper itself

Abstract

BACKGROUND AND

aimsIncreased trans fat intake has been associated with an increased risk of cardiovascular disease (CVD). While the effect of trans fat on traditional lipids is known, it's association with LDL particle number (LDL-P), a novel marker of CVD risk, has not been established. The purpose of this study was to determine the association between trans fat intake and LDL-P over 1-year among individuals participating in a lifestyle intervention trial. METHODS AND

resultsFamily members (N = 400, 33% male, mean age 48 ± 13) of patients hospitalized with CVD who participated in a 1-year randomized controlled primary prevention lifestyle intervention trial and had complete dietary data and LDL-P measures at baseline and 1-year. Change in trans fat as a percentage of total diet and mean absolute change in LDL-P at 1-year was assessed using multivariate adjusted linear regression models. At baseline, there was a significant positive correlation between dietary trans fat intake and LDL-P (Beta = 37, p = 0.04). For every 1 percent change in trans fat intake there was a 27 nmol/L change in LDL-P (Beta = 27, p = 0.04) over 1-year which was independent of baseline predictors and confounders (age, sex, smoking, statin use, waist size and physical activity; Beta = 30, p = 0.03).

conclusionA reduction in trans fat intake over 1-year was significantly associated with a reduction in LDL-P independent of potential confounders. Healthcare providers should reinforce the beneficial impact of a healthy diet, and in particular modifications in trans fat intake on improving lipid profiles.

Indexed as

Cardiovascular DiseasesCholesterol, LDLDiet, Fat-RestrictedPrimary PreventionTrans Fatty AcidsAdultDietEnergy IntakeFamilyFemaleFollow-Up StudiesHumansLife StyleMaleMiddle AgedMultivariate AnalysisCholesterol, LDLTrans Fatty AcidsCardiovascular diseaseNutritionPrevention

Identifiers

PMID24099723
PMCPMC3943937
OpenAlexW1973327204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.